Journal of Immunology Research / 2013 / Article / Fig 1

Clinical Study

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

Figure 1

(a) Trials and treatments of the two groups sectionalization. (b) Treatment protocol: cytokine-induced killer (CIK) cell transfusion cycle. Peripheral blood mononuclear cells (PBMCs) were cultured for 14 days in the presence of recombinant human interferon gamma (rhIFN-γ), recombinant human interleukin-2 (rhIL-2), and anti-CD3 monoclonal antibody before transfusion for two consecutive days. Patients were injected with rhIL-2 subcutaneously at 1 mU/day for 10 days immediately after transfusion for 10 days. Thymopentin was injected intramuscularly for 7 days before the next PBMC collection and culturing.
195691.fig.001a
(a)
195691.fig.001b
(b)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.